Changchun High-Tech Industry's (SHE:000661) unit, Shanghai Saizen Medical Technology, obtained a medical device registration certificate from the Shanghai Food and Drug Administration, according to a Shenzhen Stock Exchange disclosure on Thursday.
The certificate is for the biopharmaceutical company's luteinizing hormone detection kit (fluorescence immunochromatography), a kit used to detect luteinizing hormone in human urine samples.
The certificate is valid until Dec. 12, 2029, the disclosure said.
The company's shares slipped over 1% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。